CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway
Nancy T. Santiappillai(The University of Melbourne), Lorey Smith(Peter MacCallum Cancer Centre)
Cited by 35
Related Papers
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|34
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma
|Nature Communications|2022|29